- Filed
- May 7, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 2, 2025 | 8.73M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $58.85M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $30.79M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $31.32M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $41.22M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $113.72M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $126.03M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $66.08M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $38.67M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $164.18M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $139.81M |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 7.31M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $62K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$35.24M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | −$59.74M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | −$44.86M |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | −$5.49 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | −$5.49 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $14.94M |
| Rd Expense restated | Q1 2025 · Mar 31, 2024 | $19.49M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$40.13M |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | −$34.44M |